Results 261 to 270 of about 142,589 (348)

The laboratory billing process and its applications to molecular microbiology testing: guidance for laboratorians. [PDF]

J Clin Microbiol
Starolis MW, Kapoor H, Jurcic Smith KL, Liesman RM, Zenefski DR.   +4 more
europepmc   +1 more source

Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All

Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic, Daniel Gonzalez, Bernd Meibohm   +2 more
wiley   +1 more source

Use of and Steering to Pharmacies Owned by Insurers and Pharmacy Benefit Managers in Medicare.

JAMA Health Forum
Kakani P, Navangul S, Lee Luo C, Tormohlen KN, Kanter GP, Landrum MB, Keating NL, Bond AM.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Robust optimal excess-of-loss reinsurance and investment strategy for an insurer in a model with jumps

Scandinavian Actuarial Journal, 2018
, Yan Zeng, Hailiang Yang
exaly   +2 more sources

Hospital Prices For Commercial Plans Are Twice Those For Medicare Advantage Plans When Negotiated By The Same Insurer.

Health Affairs, 2023
Most major insurers operate in both the commercial health insurance and Medicare Advantage (MA) markets. We investigated the ratio of commercial-to-MA prices negotiated by the same insurer, in the same hospital and for the same services, using 2022 price
M. Meiselbach, Yang Wang, Jianhui Xu, Ge Bai, G. Anderson   +4 more
semanticscholar   +1 more source

Insurer Market Power And Hospital Prices In The US.

Health Affairs, 2023
The extent to which concentration in the health insurance market affects negotiated prices paid to hospitals is of high interest to policy makers. We examined the association between insurer market share and hospital prices, using a new source of data ...
A. LoSasso, Kevin Toczydlowski, Yanchao Yang   +2 more
semanticscholar   +1 more source